Compare Dropbox Inc (DBX) vs Quest Diagnostics Inc (DGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dropbox Inc vs Quest Diagnostics Inc — how do they compare? Dropbox Inc trades at $34.42 (market cap $7.42B), while Quest Diagnostics Inc trades at $229.97 (market cap $25.48B). The key difference: Quest Diagnostics Inc is far larger — about 3.4× Dropbox Inc's market cap, and Quest Diagnostics Inc pays a 1.49% dividend while Dropbox Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dropbox Inc for 97 Days and Quest Diagnostics Inc for 56 Days on average.
| DBX | DGX | |
|---|---|---|
Market Cap | $7.42B | $25.48B |
Volume | 3,061,580 | 941,866 |
Sector | Technology | Health |
52-Week High | $37.74 | $247.45 |
52-Week Low | $22.06 | $173.49 |
Typical Hold Time | 97 Days | 56 Days |
Enterprise Value | $10.29B | $31.23B |
Dividend Yield | — | 1.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dropbox (DBX) trades at $34.36, up 3.87% with bullish technical signals and consistent earnings beats. The company maintains strong profitability with 79.72% gross margins and 20.16% net income margin, though revenue growth remains flat near $2.5B. Recent news highlights insider selling and a security breach affecting 5,000 accounts, while analyst sentiment is divided with a $26.83 consensus target below current price.
The outlook is mixed with solid fundamentals but concerning valuation and insider activity. Investment opportunity lies in sustained profitability and AI integration potential, while risks include stagnant growth, high debt levels, and negative shareholder equity. Wall Street remains cautious with equal buy/hold/sell distribution.
Quest Diagnostics (DGX) trades at $230.76, up 1.66% today, reflecting strong year-to-date momentum driven by consistent earnings beats and growth in advanced diagnostics. The stock is near its 52-week high with a consensus price target of $250, indicating further upside potential. Recent news highlights partnerships, such as integration with Apple Health, and clinical study successes, though Medicare reimbursement cuts pose a headwind. Technical indicators show a bearish signal overall, with support at $228 and resistance at $232.
The outlook remains positive due to robust revenue growth, expanding profit margins, and strategic initiatives, but risks include regulatory pressure on lab payments and rising debt levels. Analyst sentiment is mixed, with a majority holding neutral ratings, suggesting cautious optimism amid execution challenges and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Dropbox Inc
Dropbox is a leading provider of cloud-storage and content collaboration tools with an emphasis on individuals and SMB. The company was founded in 2007 and was a pioneer in cloud storage and cross-platform file syncing. Utilizing inorganic and organic means, the firm has been working on diversifying its product mix and pivoting away from the cloud-storage space.
Read more on DBX →About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →
